Skip to Main Content

Author Details

Hannah Y Wen
Memorial Sloan Kettering Cancer Center
2007
118
31
PMIDPaper TitleJournal TitlePublished Year
37014972Emerging Landscape of Targeted Therapy of Breast Cancers With Low Human Epidermal Growth Factor Receptor 2 Protein Expression.Arch Pathol Lab Med2024
37925055Nonlobular Invasive Breast Carcinomas with Biallelic Pathogenic CDH1 Somatic Alterations: A Histologic, Immunophenotypic, and Genomic Characterization.Mod Pathol2024
37768520Impact of reactive changes on multigene testing: histopathologic analysis of low-grade breast cancers with high-risk 21-gene recurrence scores.Breast Cancer Res Treat2024
36323507<i>KIT</i> genetic alterations in breast cancer.J Clin Pathol2023
37612508Non-cell-autonomous cancer progression from chromosomal instability.Nature2023
37608772Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: A report of the International Immuno-Oncology Biomarker Working Group on Breast CancerJ Pathol2023
37608771Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.J Pathol2023
37353557Rare subtypes of triple negative breast cancer: Current understanding and future directions.NPJ Breast Cancer2023
37022571ASO Visual Abstract: Is Surgical Excision of Focal Atypical Ductal Hyperplasia Warranted? Experience at a Tertiary Care Center.Ann Surg Oncol2023
37179225Metaplastic Breast Cancer: Current Understanding and Future Directions.Clin Breast Cancer2023
36976395Metaplastic carcinoma of the breast: matched cohort analysis of recurrence and survival.Breast Cancer Res Treat2023
36435613Breast Cancer Pathology in the Era of Genomics.Hematol Oncol Clin North Am2023
36905438Is Surgical Excision of Focal Atypical Ductal Hyperplasia Warranted? Experience at a Tertiary Care Center.Ann Surg Oncol2023
33148628Neuroendocrine tumours of the breast: a genomic comparison with mucinous breast cancers and neuroendocrine tumours of other anatomic sites.J Clin Pathol2022
35443240Quality Issues in Diagnostic Immunohistochemistry in Breast Pathology.Pathobiology2022
35484264Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA.Nat Med2022
36269526Use of a supervised machine learning model to predict Oncotype DX risk category in node-positive patients older than 50 years of age.Breast Cancer Res Treat2022
35953528Solid-basaloid variant of adenoid cystic carcinoma of the breast with near complete response to neoadjuvant chemotherapy.NPJ Breast Cancer2022
36156357The presence of retraction clefts correlates with lymphovascular invasion and lymph node metastasis and predicts poor outcome: Analysis of 2497 breast cancer patients.Ann Diagn Pathol2022
35319017Incidence of brain metastases in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab and pertuzumab.NPJ Breast Cancer2022
35113160Examination of Low ERBB2 Protein Expression in Breast Cancer Tissue.JAMA Oncol2022
34667028Morphologic and Genomic Characteristics of Breast Cancers Occurring in Individuals with Lynch Syndrome.Clin Cancer Res2022
34751852Supervised machine learning model to predict oncotype DX risk category in patients over age 50.Breast Cancer Res Treat2022
34458945Triple-negative breast carcinomas of low malignant potential: review on diagnostic criteria and differential diagnoses.Virchows Arch2022
34599282The clinical behavior and genomic features of the so-called adenoid cystic carcinomas of the solid variant with basaloid features.Mod Pathol2022
33376197Stromal <i>MED12</i> exon 2 mutations in complex fibroadenomas of the breast.J Clin Pathol2022
32841416Next-generation assessment of human epidermal growth factor receptor 2 gene (ERBB2) amplification status in invasive breast carcinoma: a focus on Group 4 by use of the 2018 American Society of Clinical Oncology/College of American Pathologists HER2 testing guideline.Histopathology2021
33649459Morphologic and immunohistochemical features of carcinoma involving microglandular adenosis of the breast following neoadjuvant chemotherapy.Mod Pathol2021
33863915TERT promoter hotspot mutations and gene amplification in metaplastic breast cancer.NPJ Breast Cancer2021
33496354Breast conservation among older patients with early-stage breast cancer: Locoregional recurrence following adjuvant radiation or hormonal therapy.Cancer2021
34944898Assessing PD-L1 Expression Status Using Radiomic Features from Contrast-Enhanced Breast MRI in Breast Cancer Patients: Initial Results.Cancers (Basel)2021
34079072Histologic and genomic features of breast cancers with alterations affecting the SWI/SNF (SMARC) genes.Mod Pathol2021
34218258Interobserver variability in the assessment of stromal tumor-infiltrating lymphocytes (sTILs) in triple-negative invasive breast carcinoma influences the association with pathological complete response: the IVITA study.Mod Pathol2021
34294707Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma.NPJ Breast Cancer2021
34115674PD-L1 Expression in Metaplastic Breast Carcinoma Using the PD-L1 SP142 Assay and Concordance Among PD-L1 Immunohistochemical Assays.Am J Surg Pathol2021
34140615Perineural invasion as a risk factor for locoregional recurrence of invasive breast cancer.Sci Rep2021
33372007Metastasis and Immune Evasion from Extracellular cGAMP Hydrolysis.Cancer Discov2021
33393037Concordance Between 21-Gene Recurrence Scores in Multifocal or Multicentric Breast Carcinomas Differs by Age and Histologic Subtype.Ann Surg Oncol2021
33212478HER2 Immunohistochemistry in Invasive Micropapillary Breast Carcinoma: Complete Assessment of an Incomplete Pattern.Arch Pathol Lab Med2021
33417715Interobserver Variation of PD-L1 SP142 Immunohistochemistry Interpretation in Breast Carcinoma: A Study of 79 Cases Using Whole Slide Imaging.Arch Pathol Lab Med2021
33263939Whole-exome sequencing analysis of juvenile papillomatosis and coexisting breast carcinoma.J Pathol Clin Res2021
33021035The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas.Mol Oncol2021
31534203Interobserver variability in upfront dichotomous histopathological assessment of ductal carcinoma in situ of the breast: the DCISion study.Mod Pathol2020
32023457A P53-Independent DNA Damage Response Suppresses Oncogenic Proliferation and Genome Instability.Cell Rep2020
31896809Immunohistochemical analysis of IDH2 R172 hotspot mutations in breast papillary neoplasms: applications in the diagnosis of tall cell carcinoma with reverse polarity.Mod Pathol2020
31747077A phase 2 clinical trial⿯assessing the⿯efficacy and safety of pembrolizumab and radiotherapy in patients with metastatic triple-negative breast cancer.Cancer2020
32043609Whole-exome analysis of metaplastic breast carcinomas with extensive osseous differentiation.Histopathology2020
31887226Immunohistochemical assessment of HRAS Q61R mutations in breast adenomyoepitheliomas.Histopathology2020
33083532The genomic landscape of metastatic histologic special types of invasive breast cancer.NPJ Breast Cancer2020
32857242Atypical ductal hyperplasia bordering on DCIS on core biopsy is associated with higher risk of upgrade than conventional atypical ductal hyperplasia.Breast Cancer Res Treat2020
  • 1 - 50 of 118

Recommended Authors

Martin Sj??str??m
University of California-San Francisco
Career Start Year 2013
Number of shared co-authors 2
Carmen Criscitiello
University of Milano
Career Start Year 2008
Number of shared co-authors 6
Leonard Da Silva
Pathology Queensland The Royal Brisbane and Women's Hospital Brisbane Qld Australia.
Career Start Year 2007
Number of shared co-authors 7
Bora Lim
The University of Texas MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 3
Samuel Leung
University of British Columbia
Career Start Year 2007
Number of shared co-authors 10
Pamela J Provan
Westmead Institute for Medical Research, Westmead Hospital, The University of Sydney
Career Start Year 2006
Number of shared co-authors 1
Christina Yau
University of California San Francisco
Career Start Year 2005
Number of shared co-authors 4
Jeong Eon Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 2004
Number of shared co-authors 0
Andrew H Beck
Beth Israel Deaconess Medical Center, Harvard Medical School
Career Start Year 2004
Number of shared co-authors 13
Peter T Simpson
UQ Centre for Clinical Research, The University of Queensland
Career Start Year 2003
Number of shared co-authors 8
Siddhartha Deb
Olivia Newton-John Cancer Research Institute
Career Start Year 2002
Number of shared co-authors 3
Maryou B Lambros
The Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 12
Richard B Schwab
Department of Medicine and Moores Cancer Center, University of California San Diego
Career Start Year 2000
Number of shared co-authors 0
Lavinia P Middleton
The University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 4
Massimo Cristofanilli
Weill Cornell School of Medicine
Career Start Year 1998
Number of shared co-authors 5
Ingrid Hedenfalk
Lund University and Skane University Hospital
Career Start Year 1997
Number of shared co-authors 6
Naoto T Ueno
Cancer Research Center of Hawaii: University of Hawai'i Cancer Center.
Career Start Year 1995
Number of shared co-authors 2
Susan J Done
University Health Network
Career Start Year 1994
Number of shared co-authors 3
Peter Bult
Radboud University Medical Center
Career Start Year 1994
Number of shared co-authors 10
Rosemary L Balleine
Westmead Institute for Medical Research, The University of Sydney
Career Start Year 1993
Number of shared co-authors 8
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 1992
Number of shared co-authors 18
Kelly K Hunt
The University of Texas MD Anderson Cancer Center
Career Start Year 1992
Number of shared co-authors 1
Wey L Leong
University Health Network
Career Start Year 1992
Number of shared co-authors 3
Funda Meric-Bernstam
University of Texas MD Anderson Cancer Center
Career Start Year 1990
Number of shared co-authors 7
John W M Martens
Erasmus Medical Center (MC) Cancer Institute
Career Start Year 1989
Number of shared co-authors 15
Elizabeth Mallon
Queen Elizabeth University Hospital
Career Start Year 1986
Number of shared co-authors 2
Laura J Van't Veer
University of California San Francisco
Career Start Year 1984
Number of shared co-authors 14
Sunil R Lakhani
University of Queensland
Career Start Year 1983
Number of shared co-authors 19
Hans-Peter Sinn
Pathologisches Institut, Universitatsklinikum Heidelberg
Career Start Year 1981
Number of shared co-authors 11
Jeffrey S Ross
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 11

Collaborators

Jorge S Reis-Filho
Memorial Sloan-Kettering Cancer Center
Co-authored papers 49
Britta Weigelt
Memorial Sloan Kettering Cancer Center
Co-authored papers 40
Larry Norton
Memorial Sloan Kettering Cancer Center
Co-authored papers 36
Arnaud Da Cruz Paula
Memorial Sloan Kettering Cancer Center
Co-authored papers 20
Pier Selenica
Memorial Sloan Kettering Cancer Center
Co-authored papers 19
Salvatore Piscuoglio
University of Basel
Co-authored papers 12
Simon N Powell
Memorial Sloan Kettering Cancer Center
Co-authored papers 12
Charlotte K Y Ng
University of Bern
Co-authored papers 11
Felipe C Geyer
Instituto Do Cancer Do Estado de Sao Paulo
Co-authored papers 10
Clifford A Hudis
Memorial Sloan Kettering Cancer Center, USA American Society of Clinical Oncology
Co-authored papers 9
David N Brown
Memorial Sloan Kettering Cancer Center
Co-authored papers 9
Caterina Marchi??
University of Turin, Candiolo Cancer Institute, FPO-IRCCS
Co-authored papers 8
Luciano G Martelotto
Monash University
Co-authored papers 5
Rahul Kumar
Roswell Park Comprehensive Cancer Center
Co-authored papers 5
Melissa P Murray
Memorial Sloan Kettering Cancer Center
Co-authored papers 5
Nadeem Riaz
Memorial Sloan Kettering Cancer Center
Co-authored papers 5
Brian P Rubin
Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic
Co-authored papers 5
Raymond S Lim
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Francisco Beca
Stanford University School of Medicine
Co-authored papers 4
Kathleen A Burke
Brown University
Co-authored papers 4
Juan P Palazzo
Thomas Jefferson University Hospital
Co-authored papers 3
Nicola Fusco
IEO European Institute of Oncology IRCCS
Co-authored papers 3
David L Rimm
Yale University School of Medicine
Co-authored papers 3
Lajos Pusztai
Co-authored papers 3
Michael F Berger
Co-authored papers 3
José Baselga
Co-authored papers 2
James Hicks
Michelson Center for Convergent Bioscience, University of Southern California
Co-authored papers 2
Jochen K Lennerz
Massachusetts General Hospital/Harvard Medical School
Co-authored papers 2
Paula I Gonzalez-Ericsson
Co-authored papers 2
Wei Yang
Co-authored papers 2
Release 1.2